IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS

Goal of the study: to compare efficiency of anti-tuberculosis chemotherapy prescribed basing on drug susceptibility testing results obtained by GeneXpertMTB/RIF with relevant correction as per data of culture on liquid media and basing on drug susceptibility testing through culture on liquid media o...

Full description

Bibliographic Details
Main Authors: A. G. Samoylova, M. V. Burakova, I. A. Vasilieva, V. V. Lenskaya, E. V. Vaniev
Format: Article
Language:Russian
Published: New Terra Publishing House 2016-09-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/924
_version_ 1826563134993727488
author A. G. Samoylova
M. V. Burakova
I. A. Vasilieva
V. V. Lenskaya
E. V. Vaniev
author_facet A. G. Samoylova
M. V. Burakova
I. A. Vasilieva
V. V. Lenskaya
E. V. Vaniev
author_sort A. G. Samoylova
collection DOAJ
description Goal of the study: to compare efficiency of anti-tuberculosis chemotherapy prescribed basing on drug susceptibility testing results obtained by GeneXpertMTB/RIF with relevant correction as per data of culture on liquid media and basing on drug susceptibility testing through culture on liquid media only. Materials and methods. 185 pulmonary tuberculosis patients in the age from 18 to 60 years were included into the study and divided into three groups: Groups 1 and 2 included those susceptible and resistant to rifampicin respectively which was detected by GeneXpert MTB/RIF. Group 3 was formed retrospectively out of patients suffering from multiple drug resistance in whom no test systems had been used.Results. If chemotherapy regimen was appropriately chosen basing on rifampicin susceptibility data obtained only through GeneXpert MTB/RIF, the time of sputum conversion confidently did not differ for those suffering from multiple drug resistance and those without it.Prescription of chemotherapy regimen basing on GeneXpert MTB/RIF results with consequent correction as per culture results obtained by Bactec MGIT 960 confidently enhances treatment outcomes in multiple drug resistant tuberculosis patients both regarding sputum conversion rate and cavity healing compared to the group where treatment regimen was corrected basing on results of culture on liquid media. Using GeneXpert MTB/RIF significantly reduces the number of chemotherapy regimens corrections or transfers to the other regimen. Under-detection of rifampicin resistance when using GeneXpert MTB/RIF compared to Bactec MGIT 960 was fixed on the level of 1.5% (95% CI 0.42-5.44%).
first_indexed 2024-03-12T05:05:59Z
format Article
id doaj.art-b99ddb1277c649b79bd5436d189b8b24
institution Directory Open Access Journal
issn 2075-1230
2542-1506
language Russian
last_indexed 2025-03-14T09:59:09Z
publishDate 2016-09-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj.art-b99ddb1277c649b79bd5436d189b8b242025-03-02T11:22:26ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062016-09-01949182310.21292/2075-1230-2016-94-9-18-23924IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSISA. G. Samoylova0M. V. Burakova1I. A. Vasilieva2V. V. Lenskaya3E. V. Vaniev4Central Tuberculosis Research InstituteCentral Tuberculosis Research InstituteCentral Tuberculosis Research InstituteCentral Tuberculosis Research InstituteCentral Tuberculosis Research InstituteGoal of the study: to compare efficiency of anti-tuberculosis chemotherapy prescribed basing on drug susceptibility testing results obtained by GeneXpertMTB/RIF with relevant correction as per data of culture on liquid media and basing on drug susceptibility testing through culture on liquid media only. Materials and methods. 185 pulmonary tuberculosis patients in the age from 18 to 60 years were included into the study and divided into three groups: Groups 1 and 2 included those susceptible and resistant to rifampicin respectively which was detected by GeneXpert MTB/RIF. Group 3 was formed retrospectively out of patients suffering from multiple drug resistance in whom no test systems had been used.Results. If chemotherapy regimen was appropriately chosen basing on rifampicin susceptibility data obtained only through GeneXpert MTB/RIF, the time of sputum conversion confidently did not differ for those suffering from multiple drug resistance and those without it.Prescription of chemotherapy regimen basing on GeneXpert MTB/RIF results with consequent correction as per culture results obtained by Bactec MGIT 960 confidently enhances treatment outcomes in multiple drug resistant tuberculosis patients both regarding sputum conversion rate and cavity healing compared to the group where treatment regimen was corrected basing on results of culture on liquid media. Using GeneXpert MTB/RIF significantly reduces the number of chemotherapy regimens corrections or transfers to the other regimen. Under-detection of rifampicin resistance when using GeneXpert MTB/RIF compared to Bactec MGIT 960 was fixed on the level of 1.5% (95% CI 0.42-5.44%).https://www.tibl-journal.com/jour/article/view/924genexperttuberculosismultiple drug resistancecartridge test systemgenexpertculture on liquid mediatuberculosis chemotherapytuberculosis treatment
spellingShingle A. G. Samoylova
M. V. Burakova
I. A. Vasilieva
V. V. Lenskaya
E. V. Vaniev
IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
Туберкулез и болезни лёгких
genexpert
tuberculosis
multiple drug resistance
cartridge test system
genexpert
culture on liquid media
tuberculosis chemotherapy
tuberculosis treatment
title IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
title_full IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
title_fullStr IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
title_full_unstemmed IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
title_short IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
title_sort impact of express susceptibility testing to rifampicin of m tuberculosis on chemotherapy efficiency in those suffering from multiple drug resistant tuberculosis
topic genexpert
tuberculosis
multiple drug resistance
cartridge test system
genexpert
culture on liquid media
tuberculosis chemotherapy
tuberculosis treatment
url https://www.tibl-journal.com/jour/article/view/924
work_keys_str_mv AT agsamoylova impactofexpresssusceptibilitytestingtorifampicinofmtuberculosisonchemotherapyefficiencyinthosesufferingfrommultipledrugresistanttuberculosis
AT mvburakova impactofexpresssusceptibilitytestingtorifampicinofmtuberculosisonchemotherapyefficiencyinthosesufferingfrommultipledrugresistanttuberculosis
AT iavasilieva impactofexpresssusceptibilitytestingtorifampicinofmtuberculosisonchemotherapyefficiencyinthosesufferingfrommultipledrugresistanttuberculosis
AT vvlenskaya impactofexpresssusceptibilitytestingtorifampicinofmtuberculosisonchemotherapyefficiencyinthosesufferingfrommultipledrugresistanttuberculosis
AT evvaniev impactofexpresssusceptibilitytestingtorifampicinofmtuberculosisonchemotherapyefficiencyinthosesufferingfrommultipledrugresistanttuberculosis